Olanzapine vs haloperidol: treating delirium in a critical care setting

Dubois MJ, Bergeron N, Dumont M, Dial S, Skrobik Y (2001) Delirium in an intensive care unit: a study of risk factors. Intensive Care Med 27:1297–1304

Dial S, Payne J (2002) Managing delirium in the intensive care unit. Clin Pulm Med 9:260–266

Kishi Y, Iwasaki Y, Takezawa K, Kurosawa H, Endo S (1995) Delirium in critical care unit patients admitted through an emergency room. Gen Hosp Psychiatry 17:371–379

Aldemir M, Ôzen S, Hara IH, Sir A, Baç B (2001) Predisposing factors for delirium in the surgical intensive care unit. Crit Care 5:265–270

Ely EW, Guatam S, Margolin R, Francis J, May L, Speroff T, Truman B, Dittus R, Bernard GR, Inouye SK (2001) The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med 27:1892–1900

McCusker J, Cole M, Abrahamowicz M, Primeau F, Belzile E (2002) Delirium predicts 12-month mortality. Arch Intern Med 162:457–463

McGuire BE, Basten CJ, Ryan CJ, Gallagher J (2000) Intensive care unit syndrome: a dangerous misnomer. Arch Intern Med 160:906–909

Armstrong SC, Cozza KL, Watanabe KS (1997) The misdiagnosis of delirium. Psychosomatics 38:433–439

Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y (2001) Intensive care delirium screening checklist: evaluation of a new screening tool. Intensive Care Med 27:859–864

Ely EW, Inouye SK, Bernard GR, Gordon S, Francis J, May L, Truman B, Speroff T, Gautam S, Margolin R, Hart RP, Dittus R (2001) Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). J Am Med Assoc 286:2703–2710

American Psychiatric Association (1999) Practice guideline for the treatment of patients with delirium. Am J Psychiatry 156:1–20

Breitbart W, Gibson C, Tremblay A (2002) The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer—their spouses/caregivers, and their nurses. Psychosomatics 43:183–194

Menza MA, Murray GB, Holmes VF, Rafuls WA (1987) Decreased extrapyramidal symptoms with intravenous haldol. J Clin Psychiatry 48:278–280

Wise MG, Cassem NH (1998) Behavioural disturbances in the ICU. In: Civetta JM, Taylor RW, Kirby RR (eds) Critical care. Lippincott, Philadelphia, pp 1595–1604

Jacobi J, Fraser GL, Coursin DB, Riker RR, Fontaine D, Wittbrodt ET, Chalfin DB, Masica MF, Bjerke S, Coplin WM, Crippen DW, Fuchs BD, Kelleher RM, Marik PE, Nasraway SA, Murray MJ, Peruzzi WT, Lumb PD (2002) Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult. Crit Care Med 30:119–141

King DJ, Burke M, Lucas RA (1995) Antipsychotic drug-induced dysphoria. Br J Psychiatry 167:480–482

Bashford G, Bradd P (1996) Drug-induced Parkinsonism associated with dysphagia and aspiration: a brief report. J Geriatr Psychiatry Neurol 9:133

Caroff SN, Mann SC, Campbell EC (2001) Neuroleptic malignant syndrome. Adverse drug reaction bulletin, no. 209. Lippincott, Williams and Wilkins, London, pp 799–802

Ilchef R (1997) Neuroleptic-induced laryngeal dystonia can mimic anaphylaxis. Aust N Z J Psychiatry 31:877–879

Perrault LP, Denault AY, Carrier M, Cartier R, Belisle S (2000) Torsades de pointes secondary to intravenous haloperidol after coronary bypass surgery. Can J Anesth 47:251–254

Kapur S, Remington G, Jones C, Wilson A, DaSilva J, Houle S, Zipursky R (1996) High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. Am J Psychiatry 153:948–950

Sipahimalani A, Masand PS (1997) Use of risperidone in delirium: case reports. Ann Clin Psychiatry 9:105–107

Sipahimalani A, Sime RM, Masand PS (1997) Treatment of delirium with risperidone. Int J Geriatr Psychopharmacol 1:24–26

Sipahimalani A, Masand PS (1998) Olanzapine in the treatment of delirium. Psychosomatics 39:422–430

Kim K, Pae C, Chae J, Bahk W, Jun T (2001) An open pilot trial of olanzapine for delirium in the Korean population. Psychiatr Clin Neurosci 55:515–519

Breitbart W, Tremblay A, Gibson C (2002) An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients. Psychosomatics 43:175–182

Markowitz JS, Brown CS, Moore TR (1999) Atypical antipsychotics. Part I: Pharmacology, pharmacokinetics, and efficacy. Ann Pharmacother 33:73–85

American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn (DSM-IV). American Psychiatric Association, Washington, DC

Cammarano WB, Drasner K, Katz J (1998) Pain control, sedation, and use of muscle relaxants. In: Hall JB, Schmidt GA, Wood LD, (eds) Principles of critical care medicine. McGraw Hill, New York, pp 90–97

McCusker J, Cole M, Bellavance F, Primeau F (1998) Delirium: reliability and validity of a new measure of severity of delirium. Int Psychogeriatr 10:421–433

Ramsay MA, Savege TM, Simpson BR, Goodwin R (1974) Controlled sedation with aphaxalonealphadolone. Br Med J 2:656–659

Chouinard G, Ross-Chouinard A, Annable L, Jones B (1980) Extrapyramidal symptom rating scale. Can J Neurol Sci 7:233

Simpson GM, Angus JW (1970) A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 212:11–19

Skrobik Y (2002) Haloperidol should be used sparingly. Crit Care Med 30:2613–2614

Caroff S, Rosenberg H, Mann S, Campbell E, Sullivan K (2002) Neuroleptic malignant syndrome in the critical care unit. Crit Care Med 30:2609–2610

Trzepacz P (2000) Semin Clin Neuropsychiatry 5:132–148

Ross CA, Peyser CE, Shapiro I, Folstein MF (1991) Delirium: phenomenologic and etiologic subtypes. Int Psychogeriatr 3:135–147

Liptzin B, Levkoff SE (1992) An empirical study of delirium subtypes. Br J Psychiatry 161:843–845